Reasons for Discontinuation of Subcutaneous Biologic Therapy in the Treatment of Rheumatoid Arthritis: A Patient Perspective
Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s70834
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Informa UK Limited